Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19

被引:11
|
作者
Al-Benna, Sammy [1 ,2 ]
机构
[1] Stellenbosch Univ, Div Plast & Reconstruct Surg, Med & Hlth Sci, Cape Town, South Africa
[2] Tygerberg Acad Hosp, Cape Town, South Africa
关键词
angiotensin-converting enzyme 2; coronavirus; COVID-19; lungs; receptor; severe acute respiratory syndrome; skin;
D O I
10.1097/01.ASW.0000722748.73437.7d
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Binding to the angiotensin-converting enzyme 2 (ACE2) receptor is a critical step for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter target cells. This enzyme is expressed in many human tissues including the lungs, but no research has demonstrated that SARS-CoV-2 can infect human skin or subcutaneous fat tissue, despite the increasing number of reported skin manifestations. The aim of this study was to investigate ACE2 gene expression in skin using a public database. METHODS: A search of transcriptomic data sets from a public gene expression database to investigate ACE2 gene expression in human tissues. RESULTS: Human skin keratinocytes and basal cells express more ACE2 than lung epithelial cells. In contrast, both fibroblasts and melanocytes from human skin express less ACE2 than human lung epithelial cells. CONCLUSIONS: The high expression of ACE2 in keratinocytes and basal cells of human skin indicates that they may be directly susceptible to SARS-CoV-2 infection via the ACE2 receptor, especially in conditions of skin barrier dysfunction, and are therefore a potential target for the coronavirus.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [21] The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
    Harky, Amer
    Chor, Cheryl Yan Ting
    Nixon, Henry
    Jeilani, Milad
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2021, 22 (01)
  • [22] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
  • [23] Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
    Ni, Wentao
    Yang, Xiuwen
    Yang, Deqing
    Bao, Jing
    Li, Ran
    Xiao, Yongjiu
    Hou, Chang
    Wang, Haibin
    Liu, Jie
    Yang, Donghong
    Xu, Yu
    Cao, Zhaolong
    Gao, Zhancheng
    CRITICAL CARE, 2020, 24 (01)
  • [24] Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
    Wentao Ni
    Xiuwen Yang
    Deqing Yang
    Jing Bao
    Ran Li
    Yongjiu Xiao
    Chang Hou
    Haibin Wang
    Jie Liu
    Donghong Yang
    Yu Xu
    Zhaolong Cao
    Zhancheng Gao
    Critical Care, 24
  • [25] Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19
    Aloufi, Noof
    Traboulsi, Hussein
    Ding, Jun
    Fonseca, Gregory J.
    Nair, Parameswaran
    Huang, Steven K.
    Hussain, Sabah N. A.
    Eidelman, David H.
    Baglole, Carolyn J.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 320 (01) : L152 - L157
  • [26] Angiotensin-converting enzyme regulates bradykinin receptor gene expression
    Ignjacev-Lazich, I
    Kintsurashvili, E
    Johns, C
    Vitseva, O
    Duka, A
    Shenouda, S
    Gavras, I
    Gavras, H
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (05): : H1814 - H1820
  • [27] Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia
    Lunardi, Francesca
    Fortarezza, Francesco
    Vedovelli, Luca
    Pezzuto, Federica
    Boscolo, Annalisa
    Rossato, Marco
    Vettor, Roberto
    Cattelan, Anna Maria
    Del Vecchio, Claudia
    Crisanti, Andrea
    Navalesi, Paolo
    Gregori, Dario
    Calabrese, Fiorella
    BIOMOLECULES, 2021, 11 (06)
  • [28] Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
    Rangaprasad Sarangarajan
    Robert Winn
    Michael A. Kiebish
    Chas Bountra
    Elder Granger
    Niven R. Narain
    Journal of Racial and Ethnic Health Disparities, 2021, 8 : 973 - 980
  • [29] Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
    Sarangarajan, Rangaprasad
    Winn, Robert
    Kiebish, Michael A.
    Bountra, Chas
    Granger, Elder
    Narain, Niven R.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2021, 8 (04) : 973 - 980
  • [30] Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review
    Shojaee, Asma
    Vahedian-Azimi, Amir
    Faizi, Fakhrudin
    Rahimi-Bashar, Farshid
    Shahriary, Alireza
    Galeh, Hadi Esmaeili Gouvarchin
    Nehrir, Batool
    Guest, Paul C.
    Sahebkar, Amirhossein
    CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 : 53 - 68